E-cigarette exposure among high schools students in Taiwan.
Population Clinical
Consumer Use
Youth Use & Appeal
Chang (2019)
E-cigarette use and concurrent risk behaviors among adolescents.
Individual Clinical
Safety
Adverse Effects
Chang (2021)
Patterns of e-cigarette use and self-reported health outcomes among smokers and non-smokers in the United States: a preliminary assessment.
Individual Clinical
Safety; User Topography
Adverse Effects
Chang (2019)
National Estimates of ENDS Liquid Nicotine Exposures, U.S., 2013-2017.
Population Clinical
Population Health Impact
Chang (2020)
Exploring in vitro to in vivo extrapolation for exposure and health impacts of e-cigarette flavor mixtures.
Nonclinical
ALL
Chang (2021)
In vivo assessment of the toxicity of electronic cigarettes to zebrafish (Danio rerio) embryos, following gestational exposure, in terms of mortality, developmental toxicity, and hair cell damage: Toxicity of E-cigs to zebrafish embryos.
Nonclinical
Safety Effects In Animals
Acute
Chang (2021)
Characteristics and Patterns of Cigarette Smoking and Vaping By Past-Year Smokers Who Reported Using Electronic Nicotine Delivery System to Help Quit Smoking in the Past Year: Findings From the 2018-2019 Tobacco Use Supplement to the Current Population Survey.
Population Clinical
Consumer Use
Factors Influencing Patterns Of Use
Chang (2023)
The Effect of Flavored E-cigarettes on Murine allergic airways Disease.
Individual Clinical
Safety
Adverse Effects
Chapman (2019)
A randomised, open-label, cross-over clinical study to evaluate the pharmacokinetic, pharmacodynamic and safety and tolerability profiles of tobacco-free oral nicotine pouches relative to cigarettes
Individual Clinical
Pharmacokinetics & Abuse Liability
ALL
Chapman (2022)
Twenty-eight day repeated exposure of human 3D bronchial epithelial model to heated tobacco aerosols indicates decreased toxicological responses compared to cigarette smoke.
Nonclinical
Respiratory Toxicity
In Vitro
Chapman (2023)